glp 1 and alzheimers Frontiers GLP-1 Receptor Agonists in Neurodegeneration:
Description
Thats the detail most coverage of this story has buried under the financial and regulatory framing
Ozempic (semaglutide) was originally developed for type 2 diabetes, but off-label prescribing for weight loss has surged since clinical trials showed 15% body weight reduction in non-diabetic patients
And that would be a nice, easy to understand story
If you are comparing different treatment paths, our GLP-1 support guide can help you understand how these options fit into a broader weight loss plan
Fukushima, and D
